Prostacyclin prevents pericyte loss and demyelination induced by lysophosphatidylcholine in the central nervous system

Journal of Biological Chemistry

Volumn 290, Issue 18, 2015, Pages 11515-11525

  Muramatsu, Rieko ^a,b   Kuroda, Mariko ^a,b   Matoba, Ken ^a,b   Lin, Hsiaoyun ^a,b   Takahashi, Chisato ^a,b   Koyama, Yoshihisa ^a,b   Yamashita, Toshihide ^a,b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL NERVOUS SYSTEMS; DISEASE PROGRESSION; LYSOPHOSPHATIDYL-CHOLINE; NEURODEGENERATION; NEURONAL DYSFUNCTION; PATHOPHYSIOLOGICAL;

NEUROPHYSIOLOGY;

ILOPROST; LYSOPHOSPHATIDYLCHOLINE; TIGHT JUNCTION PROTEIN; PROSTACYCLIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CELL CULTURE; BRAIN PERICYTE; CELL COUNT; CELL LOSS; CONTROLLED STUDY; DEMYELINATION; DISEASE COURSE; DRUG MECHANISM; DRUG TARGETING; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MOTOR DYSFUNCTION; MOUSE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SPINAL CORD; ANIMAL; CHEMICALLY INDUCED; CYTOLOGY; DEMYELINATING DISEASES; DRUG EFFECTS; METABOLISM; MOTOR ACTIVITY; PATHOLOGY; PATHOPHYSIOLOGY; PERICYTE; SIGNAL TRANSDUCTION;

ANIMALS; BLOOD-BRAIN BARRIER; CELL COUNT; DEMYELINATING DISEASES; DISEASE PROGRESSION; EPOPROSTENOL; FEMALE; ILOPROST; LYSOPHOSPHATIDYLCHOLINES; MICE; MOTOR ACTIVITY; PERICYTES; PROTEOLYSIS; RATS; SIGNAL TRANSDUCTION; SPINAL CORD; TIGHT JUNCTION PROTEINS;

EID: 84929483899     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.587253     Document Type: Article

References (36)

1. Obermeier, B., Daneman, R., and Ransohoff, R. M. (2013) Development, maintenance and disruption of the blood-brain barrier. Nat. Med. 19, 1584-1596
2. Fortin, D. (2012) The blood-brain barrier: its influence in the treatment of brain tumors metastases. Curr. Cancer Drug Targets 12, 247-259
3. Rosenberg, G. A. (2012) Neurological diseases in relation to the blood-brain barrier. J. Cerebral. Blood Flow Metab. 32, 1139-1151
4. Shlosberg, D., Benifla, M., Kaufer, D., and Friedman, A.(2010) Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat. Rev. Neurol. 6, 393-403
5. Winkler, E. A., Bell, R. D., and Zlokovic, B. V. (2011) Central nervous system pericytes in health and disease. Nat. Neurosci. 14, 1398-1405
6. Daneman, R., Zhou, L., Kebede, A. A., and Barres, B. A. (2010) Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468, 562-566
7. Armulik, A., Genové, G., Mäe, M., Nisancioglu, M. H., Wallgard, E., Niau-det, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., Johansson, B. R., and Betsholtz, C. (2010) Pericytes regulate the blood-brain barrier. Nature 468, 557-561
8. Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., and Zlokovic, B. V. (2010) Pericytes control key neurovascular functions and neu-ronal phenotype in the adult brain and during brain aging. Neuron 68, 409-427
9. Vane, J.R., Botting, R.M. (1995) Pharmacodynamic profileofprostacyclin. Am. J. Cardiol. 75, 3A-10A
10. Huber, J. D., Egleton, R. D., and Davis, T. P. (2001) Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci. 24, 719-725
11. Terawaki, T., Takakuwa, T., Iguchi, S., Wakitani, K., Kira, H., Okegawa, T., Kawasaki, A., Masuda, Y. (1988) Effect of a prostacyclin analog OP-2507 on acute ischemic cerebral edema in cats. Eur. J. Pharmacol. 152, 63-70
12. Birukova, A. A., Wu, T., Tian, Y., Meliton, A., Sarich, N., Tian, X., Leff, A., and Birukov, K.G.(2013) Iloprost improves endothelial barrier function in lipopolysaccharide-induced lung injury. Eur. Respir. J. 41, 165-176
13. 2/LPC and ATX/LPA axes. Biochim. Biophys. Acta 1831, 42-60
14. Koizumi, S., Yamamoto, S., Hayasaka, T., Konishi, Y., Yamaguchi-Okada, M., Goto-Inoue, N., Sugiura, Y., Setou, M., and Namba, H. (2010) Imaging mass spectrometry revealed the production of lyso-phosphatidylcholine in the injured ischemic rat brain. Neuroscience 168, 219-225
15. Aguirre, A., Dupree, J. L., Mangin, J. M., and Gallo, V. (2007) A functional role for EGFR signaling in myelination and remyelination. Nat. Neurosci. 10, 990-1002
16. Bai, L., Lennon, D. P., Caplan, A. I., DeChant, A., Hecker, J., Kranso, J., Zaremba, A., and Miller, R. H. (2012) Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat. Neurosci. 15, 862-870
17. Ousman, S. S., and David, S. (2000) Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia 30, 92-104
18. Mozafari, S., Sherafat, M. A., Javan, M., Mirnajafi-Zadeh, J., and Tiraihi, T. (2010) Visual evoked potentials and MBP gene expression imply endogenous myelin repair in adult rat optic nerve and chiasm following local lysolecithin induced demyelination. Brain Res. 1351, 50-56
19. Tigges, U., Welser-Alves, J. V., Boroujerdi, A., and Milner, R. (2012) A novel and simple method for culturing pericytes from mouse brain. Mi-crovasc. Res. 84, 74-80
20. Nakagawa, S., Deli, M. A., Kawaguchi, H., Shimizudani, T., Shimono, T., Kittel, A., Tanaka, K., and Niwa, M. (2009) A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem. Int. 54, 253-263
21. Winkler, E. A., Sengillo, J. D., Bell, R. D., Wang, J., and Zlokovic, B. V. (2012) Blood-spinal cord barrier pericyte reductions contribute to increased capillary permeability. J. Cereb. Blood Flow Metab. 32, 1841-1852
22. Basso, D.M., Fisher, L. C., Anderson, A. J., Jakeman, L. B., McTigue, D. M., and Popovich, P. G. (2006) Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J. Neurotrauma 23, 635-659
23. Jeffery, N. D., and Blakemore, W. F. (1997) Locomotor deficits induced by experimental spinal cord demyelination are abolished by spontaneous re-myelination. Brain 120, 27-37
24. Nakagawa, S., Deli, M. A., Nakao, S., Honda, M., Hayashi, K., Nakaoke, R., Kataoka, Y., and Niwa, M. (2007) Pericytes from brain microvessels strengthen the barrier integrity inprimary cultures of rat brain endothelial cells. Cell. Mol. Neurobiol. 27, 687-694
25. Ousman, S. S., and David, S. (2001) MIP-1a, MCP-1, GM-CSF, and TNF-a control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord. J. Neurosci. 21, 4649-4656
26. Hsieh, C. C., Yen, M. H., Liu, H. W., and Lau, Y. T. (2000) Lysophosphatidyl-choline induces apoptotic and non-apoptotic death in vascular smooth muscle cells: in comparison with oxidized LDL. Atherosclerosis 151, 481-491
27. Qiao, J., Huang, F., Naikawadi, R. P., Kim, K. S., Said, T., and Lum, H. (2006) Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4. Am. J. Physiol. Lung Cell Mol. Physiol. 291, L91-L101
28. Cui, Y., Kataoka, Y., Satoh, T., Yamagata, A., Shirakawa, N., Watanabe, Y., Suzuki, M., Yanase, H., Kataoka, K., and Watanabe, Y. (1999) Protective effect of prostaglandin I(2) analogs on ischemic delayed neuronal damage in gerbils. Biochem. Biophys. Res. Commun. 265, 301-304
29. Takamatsu, H., Tsukada, H., Watanabe, Y., Cui, Y., Kataoka, Y., Hosoya, T., Suzuki, M., and Watanabe, Y. (2002) Specific ligand for a central type prostacyclin receptor attenuates neuronal damage in a rat model of focal cerebral ischemia. Brain Res. 925, 176-182
30. Muramatsu, R., Takahashi, C., Miyake, S., Fujimura, H., Mochizuki, H., and Yamashita, T. (2012) Angiogenesis induced by CNS inflammation promotes neuronal remodeling through vessel-derived prostacyclin. Nat. Med. 18, 1658-1664
31. Takahashi, C., Muramatsu, R., Fujimura, H., Mochizuki, H., and Yamashita, T. (2013) Prostacyclin promotes oligodendrocyte precursor recruitment and remyelination after spinal cord demyelination. Cell Death Dis. 4, e795
32. Garbuzova-Davis, S., and Sanberg, P. R.(2014) Blood-CNS barrier impairment in ALS patients versus an animal model. Front. Cell. Neurosci. 8, 21
33. Sengillo, J. D., Winkler, E. A., Walker, C. T., Sullivan, J. S., Johnson, M., and Zlokovic, B. V. (2013) Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease. Brain Pathol. 23, 303-310
34. Sagare, A. P., Bell, R. D., Zhao, Z., Ma, Q., Winkler, E. A., and Ramanathan A., et al.(2013) Pericyte loss influences Alzheimer-like neurodegeneration in mice. Nat. Commun. 4, 2932
35. Karow, M., Sánchez, R., Schichor, C., Masserdotti, G., Ortega, F., Heinrich, C., Gascón, S., Khan, M. A., Lie, D. C., Dellavalle, A., Cossu, G., Goldbrun-ner, R., Götz, M., and Berninger, B. (2012) Reprogramming of pericyte-derived cells of the adult human brain into induced neuronal cells. Cell Stem Cell 11, 471-476
36. Göritz, C., Dias, D. O., Tomilin, N., Barbacid, M., Shupliakov, O., and Frisén, J. (2011) A pericyte origin of spinal cord scar tissue. Science 333, 238-242